Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedersandoz.com
https://www.sandoz.com/rss/feeds/news/media-releases.xml
Get the latest updates from https://www.sandoz.com/rss/feeds/news/media-releases.xml directly as they happen.
Follow now 67 followers
Latest posts
Last updated about 1 year ago
Applications for proposed first-of-a-kind multiple sclerosis biosimilar natalizumab accepted by US FDA and EMA
about 1 year ago
Sandoz Supplemental Biologics License Application accepted by US FDA for biosimilar Hyrimoz® (adalimumab-adaz) high concentration formulation (HCF)
about 1 year ago
Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance
about 1 year ago
Sandoz Application for proposed biosimilar adalimumab’s high concentration formulation accepted by EMA
over 1 year ago
Sandoz launches first generic pirfenidone in US for patients with idiopathic pulmonary fibrosis, growing its respiratory portfolio
over 1 year ago
Novartis delivers solid sales and profit growth. Strong performance of in-market brands supports confidence in mid-term growth outlook
over 1 year ago